Moderna Releases Promising Data from Phase I/II Clinical Trial on mRNA-3927 for Propionic Acidemia

Early results have demonstrated that mRNA-3927 has led to a 70% reduction in the relative risk for metabolic decompensation events in patients with propionic acidemia.

Source link
#Moderna #Releases #Promising #Data #Phase #III #Clinical #Trial #mRNA3927 #Propionic #Acidemia